Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biodesix (BDSX) Net Income (2019 - 2025)

Historic Net Income for Biodesix (BDSX) over the last 7 years, with Q3 2025 value amounting to -$9.1 million.

  • Biodesix's Net Income rose 1417.42% to -$9.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$40.0 million, marking a year-over-year increase of 824.26%. This contributed to the annual value of -$42.8 million for FY2024, which is 1596.37% up from last year.
  • Biodesix's Net Income amounted to -$9.1 million in Q3 2025, which was up 1417.42% from -$11.6 million recorded in Q2 2025.
  • In the past 5 years, Biodesix's Net Income ranged from a high of -$6.2 million in Q1 2021 and a low of -$18.8 million during Q1 2023
  • Its 5-year average for Net Income is -$12.1 million, with a median of -$11.6 million in 2025.
  • Its Net Income has fluctuated over the past 5 years, first tumbled by 29234.66% in 2021, then skyrocketed by 4404.5% in 2023.
  • Biodesix's Net Income (Quarter) stood at -$13.2 million in 2021, then dropped by 24.78% to -$16.4 million in 2022, then soared by 44.05% to -$9.2 million in 2023, then increased by 8.67% to -$8.4 million in 2024, then fell by 8.62% to -$9.1 million in 2025.
  • Its Net Income was -$9.1 million in Q3 2025, compared to -$11.6 million in Q2 2025 and -$10.8 million in Q1 2025.